![Olav Zilian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Olav Zilian
Analyst-Equity presso Banque Pictet & Cie SA
Posizioni attive di Olav Zilian
Società | Posizione | Inizio | Fine |
---|---|---|---|
Banque Pictet & Cie SA
![]() Banque Pictet & Cie SA Investment ManagersFinance Banque Pictet & Cie SA is an independent Swiss private bank which specializes in asset and wealth management. Headquartered in Geneva, the firm was founded in 1805 to manage the wealth of private and institutional investors. They do not engage in investment banking and do not issue commercial, mortgage or unsecured loans. | Analyst-Equity | 01/06/2021 | - |
Gestore di Portafoglio-Azioni | 01/06/2021 | - |
Storia della carriera di Olav Zilian
Precedenti posizioni note di Olav Zilian
Società | Posizione | Inizio | Fine |
---|---|---|---|
Mirabaud Securities Ltd. (Switzerland) | Analyst-Equity | 01/03/2018 | 01/04/2021 |
MEDIGENE AG | Corporate Officer/Principal | 01/01/2016 | 01/12/2017 |
MIRSEC Partners LLP (Switzerland) | Analyst-Equity | - | - |
Swiss Institute For Experimental Cancer Research | Corporate Officer/Principal | - | - |
Baader Helvea AG
![]() Baader Helvea AG Investment Banks/BrokersFinance Baader Helvea AG (Baader Helvea) s the research-based Swiss brokerage subsidiary of Baader Bank AG (XE: BWB) in Germany. Formerly known as Helvea SA, established in 1990, the firm is located in Geneva and specializes in equity research, sales, sales trading, execution and administration, and services institutional clients worldwide, including pension funds, insurance funds, unit trusts, balanced funds and hedge funds. Their core market is Switzerland with a focus on small- and mid-cap companies; however, they also have expertise in European equity especially in those sectors in which Swiss companies operate as global players, such as banking, insurance, healthcare, food manufacturing, chemicals and luxury goods. The firm's research process focuses on company analysis and includes a company visitation program. They aim to identify companies likely to generate superior returns for shareholders and to evaluate sector or company-specific trends. | Analyst-Equity | - | - |
Formazione di Olav Zilian
University of Basel | Doctorate Degree |
University of Zurich | Doctorate Degree |
International Institute for Management Development | Masters Business Admin |
Statistiche
Distribuzione geografica
Svizzera | 9 |
Germania | 2 |
Posizioni
Analyst-Equity | 4 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 2 |
Settori
Finance | 5 |
Consumer Services | 4 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
MEDIGENE AG | Health Technology |
Aziende private | 5 |
---|---|
Banque Pictet & Cie SA
![]() Banque Pictet & Cie SA Investment ManagersFinance Banque Pictet & Cie SA is an independent Swiss private bank which specializes in asset and wealth management. Headquartered in Geneva, the firm was founded in 1805 to manage the wealth of private and institutional investors. They do not engage in investment banking and do not issue commercial, mortgage or unsecured loans. | Finance |
Baader Helvea AG
![]() Baader Helvea AG Investment Banks/BrokersFinance Baader Helvea AG (Baader Helvea) s the research-based Swiss brokerage subsidiary of Baader Bank AG (XE: BWB) in Germany. Formerly known as Helvea SA, established in 1990, the firm is located in Geneva and specializes in equity research, sales, sales trading, execution and administration, and services institutional clients worldwide, including pension funds, insurance funds, unit trusts, balanced funds and hedge funds. Their core market is Switzerland with a focus on small- and mid-cap companies; however, they also have expertise in European equity especially in those sectors in which Swiss companies operate as global players, such as banking, insurance, healthcare, food manufacturing, chemicals and luxury goods. The firm's research process focuses on company analysis and includes a company visitation program. They aim to identify companies likely to generate superior returns for shareholders and to evaluate sector or company-specific trends. | Finance |
Swiss Institute For Experimental Cancer Research | |
Mirabaud Securities Ltd. (Switzerland) | Finance |
MIRSEC Partners LLP (Switzerland) | Finance |
- Borsa valori
- Insiders
- Olav Zilian
- Esperienza